Pathologic response and surgical outcomes in patients undergoing nephrectomy following receipt of immune checkpoint inhibitors for renal cell carcinoma-Reference-Cited by-同舟云学术

Pathologic response and surgical outcomes in patients undergoing nephrectomy following receipt of immune checkpoint inhibitors for renal cell carcinoma

Published:2019-12 Issue:12 Volume:37 Page:924-931
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Singla Nirmish,Elias Roy,Ghandour Rashed A.,Freifeld Yuval,Bowman Isaac A.,Rapoport Leonid,Enikeev Mikhail,Lohrey Jay,Woldu Solomon L.^ORCID,Gahan Jeffrey C.,Bagrodia Aditya,Brugarolas James,Hammers Hans J.,Margulis Vitaly

Funder

Ruth L. Kirschstein National Research Service

University of Texas Southwestern Medical Center

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference33 articles.

1. Cancer statistics, 2018;Siegel;CA Cancer J Clin,2018

2. Howlader NNA, Krapcho M, et al. (eds). SEER cancer statistics review, 1975--2014, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2014/, based on November 2016 SEER data submission, posted to the SEER web site, April 2017.

3. Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study;Heng;J Clin Oncol,2009

4. Validation and extension of the Memorial Sloan–Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma;Mekhail;J Clin Oncol,2005

5. Overall survival and updated results for Sunitinib compared with interferon Alfa in patients with metastatic renal cell carcinoma;Motzer;J Clin Oncol,2009

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Upfront versus deferred cytoreductive nephrectomy following targeted or immunotherapy: a population-based propensity score-matched analysis of perioperative complications;World Journal of Urology;2024-07-27

2. Beyond the knife: strategic patient selection for cytoreductive nephrectomy;Current Opinion in Urology;2024-01-18

3. Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma;Scientific Reports;2024-01-17

4. Pathological Complete Response to Pembrolizumab plus Axitinib Combination following Serious Immune-Related Adverse Events in an Advanced Renal Cell Carcinoma Patient with a History of Rheumatoid Arthritis;Case Reports in Oncology;2024-01-05

5. Immune Checkpoint Inhibitor Therapy Before Nephrectomy for Locally Advanced and Metastatic Renal Cell Carcinoma;JAMA Oncology;2023-12-14